![Lloyd Rowland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lloyd Rowland
Corporate Officer/Principal chez
CYTOMX THERAPEUTICS, INC.
Fortune : 452 228 $ au 30/06/2026
Profil
Lloyd A. Rowland currently works at Rady Children's Hospital Foundation-San Diego, as Trustee and CytomX Therapeutics, Inc., as Consulting General Counsel.
Mr. Rowland also formerly worked at Alliance Pharmaceutical Corp., as Secretary, Vice President & General Counsel from 1993 to 2001, Amylin Pharmaceuticals, Inc., as Chief Compliance Officer, VP & General Counsel from 2011 to 2013, Xencor, Inc., as Secretary, Chief Compliance Officer & Senior VP from 2015 to 2017, and Imperial Savings Association (Amarillo, Texas), as VP, Senior Counsellor-Finance & Securities in 2009.
Mr. Rowland received his undergraduate degree from Southern Methodist University and graduate degree from Emory University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2025 | 120 594 ( 0,07 % ) | 452 228 $ | 30/06/2026 |
Postes actifs de Lloyd Rowland
| Sociétés | Poste | Début |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Rady Children's Hospital Foundation-San Diego
 Rady Children's Hospital Foundation-San Diego Other Consumer ServicesConsumer Services Provides healthcare support services | Directeur/Membre du Conseil | 10/02/2011 |
Anciens postes connus de Lloyd Rowland
| Sociétés | Poste | Fin |
|---|---|---|
| XENCOR, INC. | Compliance Officer | 01/02/2017 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Compliance Officer | - |
Alliance Pharmaceutical Corp.
 Alliance Pharmaceutical Corp. BiotechnologyHealth Technology Develops medical and pharmaceutical products | Conseiller Juridique Général | 01/01/2001 |
Imperial Savings Association (Amarillo, Texas)
 Imperial Savings Association (Amarillo, Texas) Savings BanksFinance Engages in federal and state savings & loans | Corporate Officer/Principal | - |
Formation de Lloyd Rowland
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Alliance Pharmaceutical Corp.
Alliance Pharmaceutical Corp. BiotechnologyHealth Technology Develops medical and pharmaceutical products | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imperial Savings Association (Amarillo, Texas)
Imperial Savings Association (Amarillo, Texas) Savings BanksFinance Engages in federal and state savings & loans | Finance |
Rady Children's Hospital Foundation-San Diego
Rady Children's Hospital Foundation-San Diego Other Consumer ServicesConsumer Services Provides healthcare support services | Consumer Services |
Emory University School of Law
 Emory University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
